{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:38:53Z","timestamp":1785332333644,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00277-015-2301-7","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T06:05:27Z","timestamp":1422857127000},"page":"975-980","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["General features and epidemiology of lymphoma in Colombia. A multicentric study"],"prefix":"10.1007","volume":"94","author":[{"given":"Juan F.","family":"Combariza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Lombana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"2301_CR1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn (International Agency for Research on Cancer","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn (International Agency for Research on Cancer. World Health Organization, Lyon"},{"key":"2301_CR2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","volume":"9","author":"JR Anderson","year":"1998","unstructured":"Anderson JR, Armitage JO, Weisenburger DD (1998) Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol 9:717\u2013720","journal-title":"Ann Oncol"},{"key":"2301_CR3","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J (2008) Weisenburger D; International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124\u20134130","journal-title":"J Clin Oncol"},{"key":"2301_CR4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1746-1596-6-77","volume":"6","author":"QP Yang","year":"2011","unstructured":"Yang QP, Zhang WY, Yu JB et al (2011) Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 6:77","journal-title":"Diagn Pathol"},{"key":"2301_CR5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ajh.21824","volume":"85","author":"SO Yoon","year":"2010","unstructured":"Yoon SO, Suh C, Lee DH et al (2010) Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification. Am J Hematol 85:760\u2013764","journal-title":"Am J Hematol"},{"key":"2301_CR6","unstructured":"Murillo RH, Pi\u00f1eros M, Acosta JA, Castellanos VH (2012) Instituto Nacional de Cancerolog\u00eda Anuario Estad\u00edstico 2010. Volumen 8 (Instituto Nacional de Cancerolog\u00eda: Bogot\u00e1, Colombia)"},{"key":"2301_CR7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u201386","journal-title":"J Clin Oncol"},{"key":"2301_CR8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrc1948","volume":"6","author":"DM Parkin","year":"2006","unstructured":"Parkin DM (2006) The evolution of the population-based cancer registry. Nat Rev Cancer 6:603\u2013612","journal-title":"Nat Rev Cancer"},{"key":"2301_CR9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(12)60035-X","volume":"380","author":"W Townsend","year":"2012","unstructured":"Townsend W, Linch D (2012) Hodgkin's lymphoma in adults. Lancet 380:836\u2013847","journal-title":"Lancet"},{"key":"2301_CR10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2559.2010.03696.x","volume":"58","author":"E Roman","year":"2011","unstructured":"Roman E, Smith AG (2011) Epidemiology of lymphomas. Histopathology 58:4\u201314","journal-title":"Histopathology"},{"key":"2301_CR11","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland KR, Armitage JO, Hancock BW (2012) Non-Hodgkin lymphoma. Lancet 380:848\u2013857","journal-title":"Lancet"},{"key":"2301_CR12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/2193-1801-2-70","volume":"2","author":"S Novelli","year":"2013","unstructured":"Novelli S, Briones J, Sierra J (2013) Epidemiology of lymphoid malignancies: last decade update. Springerplus 2:70","journal-title":"Springerplus"},{"key":"2301_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hon.826","volume":"25","author":"S Luminari","year":"2007","unstructured":"Luminari S, Cesaretti M, Rashid I et al (2007) Incidence, clinical characteristics and survival of malignant lymphomas: a population based study from cancer registry in northern Italy. Hematol Oncol 25:189\u2013197","journal-title":"Hematol Oncol"},{"key":"2301_CR14","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1182\/blood-2012-07-440073","volume":"120","author":"J Laurini","year":"2012","unstructured":"Laurini J, Perry A, Boilesen E et al (2012) Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases. Blood 120:4795\u20134801","journal-title":"Blood"},{"key":"2301_CR15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107:265\u201376","journal-title":"Blood"},{"key":"2301_CR16","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1200\/JCO.2010.32.7577","volume":"29","author":"S Montoto","year":"2011","unstructured":"Montoto S, Fitzgibbon J (2011) Transformation of Indolent B-Cell Lymphomas. J Clin Oncol 29:1827\u201334","journal-title":"J Clin Oncol"},{"key":"2301_CR17","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3109\/10428194.2011.584254","volume":"52","author":"AM Perry","year":"2011","unstructured":"Perry AM, Molina-Kirsch KH, Nathwani BN et al (2011) Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system. Leuk Lymphoma 52:1681\u20131688","journal-title":"Leuk Lymphoma"},{"key":"2301_CR18","first-page":"177","volume":"60","author":"RH Morrow Jr","year":"1985","unstructured":"Morrow RH Jr (1985) Epidemiological evidence for the role of falciparum malaria in the pathogenesis of Burkitt's lymphoma. IARC Sci Publ 60:177\u201386","journal-title":"IARC Sci Publ"},{"key":"2301_CR19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","volume":"350","author":"DA Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein\u2013Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328\u20131337","journal-title":"N Engl J Med"},{"key":"2301_CR20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semcancer.2009.10.002","volume":"19","author":"A Chene","year":"2009","unstructured":"Chene A, Donati D, Orem J et al (2009) Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus. Semin Cancer Biol 19:411\u201320","journal-title":"Semin Cancer Biol"},{"key":"2301_CR21","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa022473","volume":"348","author":"V Diehl","year":"2003","unstructured":"Diehl V, Franklin J, Pfreundschuh M et al (2003) Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 348:2386\u201395","journal-title":"N Engl J Med"},{"key":"2301_CR22","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"W Hiddemann","year":"2005","unstructured":"Hiddemann W, Kneba M, Dreyling M et al (2005) Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 106:3725\u201332","journal-title":"Blood"},{"key":"2301_CR23","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","volume":"23","author":"LH Sehn","year":"2005","unstructured":"Sehn LH, Donaldson J, Chhanabhai M et al (2005) Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 23:5027\u201333","journal-title":"J Clin Oncol"},{"key":"2301_CR24","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(13)60313-X","volume":"381","author":"D Cunningham","year":"2013","unstructured":"Cunningham D, Hawkes EA, Jack A et al (2013) Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles. Lancet 381:1817\u201326","journal-title":"Lancet"},{"key":"2301_CR25","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(10)61381-5","volume":"376","author":"M Hallek","year":"2010","unstructured":"Hallek M, Fischer K, Fingerle-Rowson G et al (2010) Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 376:1164\u201374","journal-title":"Lancet"},{"key":"2301_CR26","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/cncr.25765","volume":"117","author":"PJ Shenoy","year":"2011","unstructured":"Shenoy PJ, Malik N, Nooka A et al (2011) Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer 117:2530\u201340","journal-title":"Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2301-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2301-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2301-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:49:57Z","timestamp":1559036997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2301-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2301"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2301-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}